| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4034688
[patent_doc_number] => 05994525
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-30
[patent_title] => 'Nucleic acid encoding Actinobacillus pleuropneumoniae cytolytic proteins'
[patent_app_type] => 1
[patent_app_number] => 8/488706
[patent_app_country] => US
[patent_app_date] => 1995-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 19
[patent_no_of_words] => 24296
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/994/05994525.pdf
[firstpage_image] =>[orig_patent_app_number] => 488706
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/488706 | Nucleic acid encoding Actinobacillus pleuropneumoniae cytolytic proteins | Jun 8, 1995 | Issued |
Array
(
[id] => 3821631
[patent_doc_number] => 05783197
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-21
[patent_title] => 'Eimeria polypeptide antigen and vaccines containing the same'
[patent_app_type] => 1
[patent_app_number] => 8/473466
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4658
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/783/05783197.pdf
[firstpage_image] =>[orig_patent_app_number] => 473466
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/473466 | Eimeria polypeptide antigen and vaccines containing the same | Jun 6, 1995 | Issued |
| 08/481652 | VACCINES SYNTHESIZED BY TRANSGENIC PLANTS | Jun 6, 1995 | Abandoned |
Array
(
[id] => 3820832
[patent_doc_number] => 05730989
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-24
[patent_title] => 'Oral vaccine against gram negative bacterial infection'
[patent_app_type] => 1
[patent_app_number] => 8/482552
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 4891
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/730/05730989.pdf
[firstpage_image] =>[orig_patent_app_number] => 482552
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/482552 | Oral vaccine against gram negative bacterial infection | Jun 6, 1995 | Issued |
Array
(
[id] => 3828911
[patent_doc_number] => 05814320
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-29
[patent_title] => 'Eimeria tenella polypeptide and vaccine containing same'
[patent_app_type] => 1
[patent_app_number] => 8/473468
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 19
[patent_no_of_words] => 8829
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/814/05814320.pdf
[firstpage_image] =>[orig_patent_app_number] => 473468
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/473468 | Eimeria tenella polypeptide and vaccine containing same | Jun 6, 1995 | Issued |
| 08/467152 | PCTD PLASMID ISOLATED FROM CHLAMYDIA TRACHOMATIS SEROTYPE D, ITS GENES AND PROTEINS ENCODED BY THEM; RECOMBINANT PLASMIDS FOR THE EXPRESSION OF SAID GENES IN HETEROLOGOUS SYSTEMS AND FUSED RECOMBINANT PROTEINS, PREPARATION OF SAID RECOMBINANT PROTEINS AND | Jun 5, 1995 | Abandoned |
Array
(
[id] => 3701721
[patent_doc_number] => 05653986
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-05
[patent_title] => 'Vibrio cholerae bengal serogroup-O139 capsular polysaccharide and protein conjugates thereof'
[patent_app_type] => 1
[patent_app_number] => 8/465905
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4797
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/653/05653986.pdf
[firstpage_image] =>[orig_patent_app_number] => 465905
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/465905 | Vibrio cholerae bengal serogroup-O139 capsular polysaccharide and protein conjugates thereof | Jun 5, 1995 | Issued |
Array
(
[id] => 4038345
[patent_doc_number] => 05874083
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-23
[patent_title] => 'Immunopotentiating complexes comprising TraT proteins'
[patent_app_type] => 1
[patent_app_number] => 8/461324
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 5260
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/874/05874083.pdf
[firstpage_image] =>[orig_patent_app_number] => 461324
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/461324 | Immunopotentiating complexes comprising TraT proteins | Jun 4, 1995 | Issued |
Array
(
[id] => 3623170
[patent_doc_number] => 05686080
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-11
[patent_title] => 'Parasitic helminth p4 proteins'
[patent_app_type] => 1
[patent_app_number] => 8/459019
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19371
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/686/05686080.pdf
[firstpage_image] =>[orig_patent_app_number] => 459019
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/459019 | Parasitic helminth p4 proteins | Jun 1, 1995 | Issued |
Array
(
[id] => 3843130
[patent_doc_number] => 05766608
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'DNA molecules which encode the fimbrin protein of Haemophilus influenzae'
[patent_app_type] => 1
[patent_app_number] => 8/457997
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 10
[patent_no_of_words] => 7467
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/766/05766608.pdf
[firstpage_image] =>[orig_patent_app_number] => 457997
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/457997 | DNA molecules which encode the fimbrin protein of Haemophilus influenzae | May 31, 1995 | Issued |
Array
(
[id] => 3734521
[patent_doc_number] => 05753238
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-19
[patent_title] => 'Target antigens of transmission blocking antibodies for malaria parasites'
[patent_app_type] => 1
[patent_app_number] => 8/454039
[patent_app_country] => US
[patent_app_date] => 1995-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9412
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/753/05753238.pdf
[firstpage_image] =>[orig_patent_app_number] => 454039
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/454039 | Target antigens of transmission blocking antibodies for malaria parasites | May 29, 1995 | Issued |
Array
(
[id] => 3650373
[patent_doc_number] => 05684145
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-04
[patent_title] => 'Carrier system against GNRH'
[patent_app_type] => 1
[patent_app_number] => 8/453588
[patent_app_country] => US
[patent_app_date] => 1995-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11696
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/684/05684145.pdf
[firstpage_image] =>[orig_patent_app_number] => 453588
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/453588 | Carrier system against GNRH | May 29, 1995 | Issued |
Array
(
[id] => 3873003
[patent_doc_number] => 05804198
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-08
[patent_title] => 'Vaccines against disease caused by pathogenic pilus-forming bacteria'
[patent_app_type] => 1
[patent_app_number] => 8/447685
[patent_app_country] => US
[patent_app_date] => 1995-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17986
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/804/05804198.pdf
[firstpage_image] =>[orig_patent_app_number] => 447685
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/447685 | Vaccines against disease caused by pathogenic pilus-forming bacteria | May 22, 1995 | Issued |
| 08/443514 | VACCINE DELIVERY SYSTEM | May 17, 1995 | Abandoned |
Array
(
[id] => 3489278
[patent_doc_number] => 05536496
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-16
[patent_title] => 'Pasteurella multocida toxoid vaccines'
[patent_app_type] => 1
[patent_app_number] => 8/439714
[patent_app_country] => US
[patent_app_date] => 1995-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10035
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/536/05536496.pdf
[firstpage_image] =>[orig_patent_app_number] => 439714
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/439714 | Pasteurella multocida toxoid vaccines | May 11, 1995 | Issued |
| 08/432692 | USE OF EXTRACELLULAR CYSTEINE PROTEASE TO INHIBIT CELL PROLIFERATION | Apr 30, 1995 | Abandoned |
Array
(
[id] => 3742831
[patent_doc_number] => 05753787
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-19
[patent_title] => 'Nucleic acids encoding ancylostoma secreted protein'
[patent_app_type] => 1
[patent_app_number] => 8/419414
[patent_app_country] => US
[patent_app_date] => 1995-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13120
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/753/05753787.pdf
[firstpage_image] =>[orig_patent_app_number] => 419414
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/419414 | Nucleic acids encoding ancylostoma secreted protein | Apr 9, 1995 | Issued |
Array
(
[id] => 3892828
[patent_doc_number] => 05834591
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-10
[patent_title] => 'Polypeptides and antibodies useful for the diagnosis and treatment of pathogenic neisseria and other microorganisms having type 4 pilin'
[patent_app_type] => 1
[patent_app_number] => 8/415788
[patent_app_country] => US
[patent_app_date] => 1995-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 28037
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/834/05834591.pdf
[firstpage_image] =>[orig_patent_app_number] => 415788
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/415788 | Polypeptides and antibodies useful for the diagnosis and treatment of pathogenic neisseria and other microorganisms having type 4 pilin | Apr 2, 1995 | Issued |
Array
(
[id] => 3873031
[patent_doc_number] => 05804200
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-08
[patent_title] => 'Parasitic nematode proteins and vaccines'
[patent_app_type] => 1
[patent_app_number] => 8/408120
[patent_app_country] => US
[patent_app_date] => 1995-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 71
[patent_no_of_words] => 20692
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/804/05804200.pdf
[firstpage_image] =>[orig_patent_app_number] => 408120
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/408120 | Parasitic nematode proteins and vaccines | Mar 19, 1995 | Issued |
Array
(
[id] => 3787048
[patent_doc_number] => 05780041
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-14
[patent_title] => '39-kilodalton antigen specific to Borrelia burgdorferi'
[patent_app_type] => 1
[patent_app_number] => 8/396957
[patent_app_country] => US
[patent_app_date] => 1995-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 11611
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/780/05780041.pdf
[firstpage_image] =>[orig_patent_app_number] => 396957
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/396957 | 39-kilodalton antigen specific to Borrelia burgdorferi | Feb 28, 1995 | Issued |